Ask AI
Stephan Stilgenbauer

Stephan Stilgenbauer, MD

Medical Director Comprehensive Cancer Center Ulm (CCCU)
Head Early Clinical Trials Unit (ECTU)
Head Division of CLL Department of Internal Medicine III
Comprehensive Cancer Center Ulm (CCCU)
University of Medical Center Ulm
Ulm, Germany

Explore Activities by Stephan Stilgenbauer

Title
Format
Credit Type
Credits
International Perspectives on Developments and Decision-making Tools for Frontline Treatment of CLL/SLL

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--
Eine globale Initiative zur Verbesserung der Versorgung bei rezidivierter/refraktärer CLL

Content Format:

PDF

Credit Type:

--

Credits:

--
Appel mondial à l'action pour améliorer les soins dans le traitement de la LLC récidivante ou réfractaire

Content Format:

PDF

Credit Type:

--

Credits:

--
Una iniziativa internazionale per migliorare la cura della LLC recidivata/refrattaria

Content Format:

PDF

Credit Type:

--

Credits:

--
Llamamiento a la acción para mejorar resultados en el manejo de la leucemia linfocítica crónica (LLC) recidivante/refractaria al tratamiento oncológico  

Content Format:

PDF

Credit Type:

--

Credits:

--
Global Guide to First-line Treatment for CLL/SLL

Content Format:

Slideset

Credit Type:

--

Credits:

--
On the Frontlines of CLL/SLL: International Perspectives on First-line Treatments for CLL/SLL

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.00
A Global Call to Action for Advancing Care in Relapsed/Refractory CLL 

Content Format:

Clinical Thought

Credit Type:

AAPA | ACPE | AMA | ANCC

Credits:

0.25
Interactive Tool for the Frontline Treatment of CLL: An International Expert Perspective

Content Format:

Tool

Credit Type:

--

Credits:

--
Interactive Tool With Expert Guidance for the Treatment of CLL: An International Perspective

Content Format:

Tool

Credit Type:

--

Credits:

--
Global Guide to BTK Inhibitor Treatment Decisions and AE Management in CLL 

Content Format:

Slideset

Credit Type:

--

Credits:

--
Global Perspectives and Clinical Resources to Guide Treatment Decisions and Management of Adverse Events With BTK Inhibitor Therapy in CLL 

Content Format:

Text Module

Credit Type:

AMA

Credits:

1.00
Interactive Tool to Guide Management of Adverse Events With BTK Inhibitor Therapy in Hematologic Malignancies

Content Format:

Tool

Credit Type:

--

Credits:

--
Expert Guidance for the Treatment of CLL: An International Perspective

Content Format:

Tool

Credit Type:

--

Credits:

--
A Year in Review: Expert Perspectives on Current and Emerging Data With BTK Inhibitors for CLL and MCL

Content Format:

Text Module

Credit Type:

AMA

Credits:

0.50
A Year in Review and a Look to the Future: BTKi in CLL and MCL

Content Format:

Podcast Episodes

Credit Type:

--

Credits:

--
Interactive Tool for Managing BTK Inhibitor−Associated AEs in Hematologic Malignancies: A Global Perspective

Content Format:

Tool

Credit Type:

--

Credits:

--
Expert Guidance for the Treatment of CLL: An International Perspective

Content Format:

Tool

Credit Type:

--

Credits:

--
BTK Inhibitor Therapy for CLL: An International Perspective

Content Format:

Clinical Thought

Credit Type:

--

Credits:

--